Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI
Neoadjuvant chemotherapy (NAC) before radical cystectomy is standard of care in patients with muscle-invasive bladder cancer (MIBC). Response assessment after NAC is important but suboptimal using CT. We asses...
Source: Cancer Imaging - Category: Radiology Authors: Sungmin Woo, Anton S. Becker, Jeeban P. Das, Soleen Ghafoor, Yuki Arita, Nicole Benfante, Natalie Gangai, Min Yuen Teo, Alvin C. Goh and Hebert A. Vargas Tags: Research article Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology